105 related articles for article (PubMed ID: 22417142)
1. Is MMP-7 gene polymorphism a possible risk factor for chronic obstructive pulmonary disease in Turkish patients.
Mogulkoc U; Coskunpinar E; Aynaci E; Cağlar E; Ortakoylu MG; Ozkan G; Oltulu YM; Eraltan IY
Genet Test Mol Biomarkers; 2012 Jun; 16(6):519-23. PubMed ID: 22417142
[TBL] [Abstract][Full Text] [Related]
2. Matrix Metalloproteinase-9 (279R/Q) Polymorphism is Associated with Clinical Severity and Airflow Limitation in Tunisian Patients with Chronic Obstructive Pulmonary Disease.
Bchir S; Nasr HB; Hakim IR; Anes AB; Yacoub S; Garrouch A; Benzarti M; Bauvois B; Tabka Z; Chahed K
Mol Diagn Ther; 2015 Dec; 19(6):375-87. PubMed ID: 26303146
[TBL] [Abstract][Full Text] [Related]
3. MMP-3 (-1171 5A/6A; Lys45Glu) variants affect serum levels of matrix metalloproteinase (MMP)-3 and correlate with severity of COPD: A study of MMP-3, MMP-7 and MMP-12 in a Tunisian population.
Bchir S; Ben Nasr H; Garrouch A; Ben Anes A; Abbassi A; Tabka Z; Chahed K
J Gene Med; 2018 Jan; 20(1):. PubMed ID: 29165854
[TBL] [Abstract][Full Text] [Related]
4. MMP-2 (-1306 C/T) Polymorphism Affects Serum Matrix Metalloproteinase (MMP)-2 Levels and Correlates with Chronic Obstructive Pulmonary Disease Severity: A Case-Control Study of MMP-1 and -2 in a Tunisian Population.
Bchir S; Nasr HB; Anes AB; Benzarti M; Garrouch A; Tabka Z; Chahed K
Mol Diagn Ther; 2016 Dec; 20(6):579-590. PubMed ID: 27412345
[TBL] [Abstract][Full Text] [Related]
5. The association of genetic polymorphisms of hypoxia inducible factor-1 alpha and vascular endothelial growth factor with increased risk of chronic obstructive pulmonary disease: A case-control study.
Yu ZG; Wang BZ; Cheng ZZ
Kaohsiung J Med Sci; 2017 Sep; 33(9):433-441. PubMed ID: 28865600
[TBL] [Abstract][Full Text] [Related]
6. [Study on matrix metalloproteinase 1, 9, 12 polymorphisms and susceptibility to chronic obstructive pulmonary disease among Han nationality in northern China].
Zhang RB; He QY; Yang RH; Lu BB; Liu YJ
Zhonghua Liu Xing Bing Xue Za Zhi; 2005 Nov; 26(11):907-10. PubMed ID: 16676616
[TBL] [Abstract][Full Text] [Related]
7. Stromelysin-1 polymorphism as a new potential risk factor in progression of chronic obstructive pulmonary disease.
Santus P; Casanova F; Biondi ML; Blasi F; Di Marco F; Centanni S
Monaldi Arch Chest Dis; 2009 Mar; 71(1):15-20. PubMed ID: 19522160
[TBL] [Abstract][Full Text] [Related]
8. The polymorphism -2548G/A in leptin and severity of chronic obstructive pulmonary disease.
Ye XW; Xiao M; Ye J; Zhang XY; Xiao J; Feng YL; Wen FQ
Int J Immunogenet; 2011 Feb; 38(1):45-50. PubMed ID: 20854423
[TBL] [Abstract][Full Text] [Related]
9. The relationship of metalloproteinase gene polymorphisms and lung cancer.
Sanli M; Akar E; Pehlivan S; Bakır K; Tuncozgur B; Isik AF; Pehlivan M; Elbeyli L
J Surg Res; 2013 Aug; 183(2):517-23. PubMed ID: 23465389
[TBL] [Abstract][Full Text] [Related]
10. Effect of polymorphisms in the β2-adrenergic receptor on the susceptibility and pulmonary function of patients with chronic obstructive pulmonary disease: a meta analysis.
Niu LM; Liang Y; Xu M; Zhang YY; Zhang Y; He B
Chin Med J (Engl); 2012 Jun; 125(12):2213-8. PubMed ID: 22884155
[TBL] [Abstract][Full Text] [Related]
11. [Surfactant protein A gene polymorphisms in chronic obstructive pulmonary disease].
Xie JG; Xu YJ; Zhang ZX; Ni W; Chen SX
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2005 Feb; 22(1):91-3. PubMed ID: 15696492
[TBL] [Abstract][Full Text] [Related]
12. Genetic polymorphism in matrix metalloproteinase-9 and the susceptibility to chronic obstructive pulmonary disease in Han population of south China.
Zhou M; Huang SG; Wan HY; Li B; Deng WW; Li M
Chin Med J (Engl); 2004 Oct; 117(10):1481-4. PubMed ID: 15498369
[TBL] [Abstract][Full Text] [Related]
13. Genetic polymorphisms of cytochrome p450 and matrix metalloproteinase in chronic obstructive pulmonary disease.
Cheng SL; Yu CJ; Yang PC
Biochem Genet; 2009 Aug; 47(7-8):591-601. PubMed ID: 19507017
[TBL] [Abstract][Full Text] [Related]
14. Is TNF-α gene polymorphism related to pulmonary functions and prognosis as determined by FEV1, BMI, COPD exacerbation and hospitalization in patients with smoking-related COPD in a Turkish population?
Özdoğan N; Tutar N; Demir R; Saatçi Ç; Kanbay A; Büyükoğlan H
Rev Port Pneumol; 2014; 20(6):305-10. PubMed ID: 24818527
[TBL] [Abstract][Full Text] [Related]
15. Matrix metalloproteinase-9 promoter polymorphism associated with upper lung dominant emphysema.
Ito I; Nagai S; Handa T; Muro S; Hirai T; Tsukino M; Mishima M
Am J Respir Crit Care Med; 2005 Dec; 172(11):1378-82. PubMed ID: 16126934
[TBL] [Abstract][Full Text] [Related]
16. Association Between ADRB2 Genetic Polymorphisms and the Risk of Chronic Obstructive Pulmonary Disease: A Case-Control Study in a Chinese Population.
Zhao H; Wu X; Dong CL; Wang BY; Zhao J; Cao XE
Genet Test Mol Biomarkers; 2017 Aug; 21(8):491-496. PubMed ID: 28753063
[TBL] [Abstract][Full Text] [Related]
17. Association of
Ozretić P; da Silva Filho MI; Catalano C; Sokolović I; Vukić-Dugac A; Šutić M; Kurtović M; Bubanović G; Popović-Grle S; Skrinjarić-Cincar S; Vugrek O; Jukić I; Rumora L; Bosnar M; Samaržija M; Bals R; Jakopović M; Försti A; Knežević J
Genes (Basel); 2019 Oct; 10(10):. PubMed ID: 31601004
[TBL] [Abstract][Full Text] [Related]
18. Role of proteinase-activated receptor-1 gene polymorphisms in susceptibility to chronic obstructive pulmonary disease.
Yun CM; Sang XY
Genet Mol Res; 2015 Oct; 14(4):13215-20. PubMed ID: 26535635
[TBL] [Abstract][Full Text] [Related]
19. Association of the CYP1A1 MspI and TNFα-308 polymorphisms with chronic obstructive pulmonary disease in Inner Mongolia.
Yang L; Li F; Yan M; Su X
Genet Mol Res; 2014 Apr; 13(2):3209-17. PubMed ID: 24841653
[TBL] [Abstract][Full Text] [Related]
20. Association of matrix metalloproteinase-7 (-181A/G) promoter polymorphism in chronic pancreatitis.
Manjari KS; Jyothy A; Kumar PS; Prabhakar B; Nallari P; Venkateshwari A
Indian J Med Res; 2014 Nov; 140(5):609-15. PubMed ID: 25579141
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
